SEC Info - 9 Meters Biopharma, Inc. - ‘8-K’ for 4/21/21

SEC Info℠

Home

Help

Please Sign In

9 Meters Biopharma, Inc. – ‘8-K’ for 4/21/21

On: Wednesday, 4/21/21, at 7:33am ET · For: 4/21/21 · Accession #: 1551986-21-54 · File #: 1-37797

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/21/21  9 Meters Biopharma, Inc.          8-K:8,9     4/21/21   13:358K

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     28K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     13K 
 9: R1          Cover                                               HTML     49K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- nmtr-20210421_htm                   XML     23K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.CAL  XBRL Calculations -- nmtr-20210421_cal               XML      7K 
 5: EX-101.DEF  XBRL Definitions -- nmtr-20210421_def                XML      9K 
 6: EX-101.LAB  XBRL Labels -- nmtr-20210421_lab                     XML     72K 
 7: EX-101.PRE  XBRL Presentations -- nmtr-20210421_pre              XML     36K 
 3: EX-101.SCH  XBRL Schema -- nmtr-20210421                         XSD     11K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               13±    18K 
13: ZIP         XBRL Zipped Folder -- 0001551986-21-000054-xbrl      Zip     15K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C:

nmtr-20210421

i 0001551986 i FALSE00015519862021-04-212021-04-21

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): i April 21, 2021

i 9 Meters Biopharma, Inc.

(Exact name of registrant as specified in its charter)

i Delaware

i 001-37797

i 27-3948465

(State or other jurisdiction of
incorporation or organization)

(Commission
File Number)

(I.R.S. Employer
Identification No.)

i 8480 Honeycutt Road, i Suite 120, i Raleigh, i NC i 27615

(Address of principal executive offices) (Zip Code)

( i 919) i 275-1933

(Registrant’s telephone number, include area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


i ☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


i ☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


i ☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


i ☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Common Stock $0.0001 Par Value	i NMTR	i The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company i ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. i ☒


Item 8.01.			Other Events.

On April 21, 2021, 9 Meters Biopharma, Inc. announced it will participate in the Truist Securities 7th Annual Life Sciences Summit. A copy of such release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.


Item 9.01.			Financial Statements and Exhibits.

(d) Exhibits


Exhibit No.			Description
Exhibit 99.1			Press Release dated April 21, 2021.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



	9 Meters Biopharma, Inc.

Date: April 21, 2021	By:	/s/ *Edward J. Sitar*
		Edward J. Sitar
		Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	4/21/21	None on these Dates
		List all Filings

↑Top

Filing Submission 0001551986-21-000054 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)